escalation of adjuvant therapy in hr breast cancer
Published 3 years ago • 64 plays • Length 2:20Download video MP4
Download video MP3
Similar videos
-
1:19
optimizing adjuvant therapy: chemotherapy necessity in hr-positive breast cancer
-
1:56
optimizing adjuvant treatment in hr /her2- early breast cancer
-
1:24
treatment de-escalation and escalation strategies in her2-positive breast cancer
-
0:54
treatment de-escalation in premenopausal patients with hr /her2- breast cancer and micro-metastasis
-
0:54
de-escalation of radiation therapy after primary systemic therapy in non-metastatic breast cancer
-
1:52
tils as a prognostic biomarker for treatment de-escalation in her2-positive breast cancer
-
6:09
adjuvant endocrine therapy for breast cancer: optimal durations and regimens
-
1:01
future of breast cancer care: her2 therapies in earlier settings & de-escalation
-
1:38
unanswered questions in the use of adjuvant therapy in early breast cancer
-
2:10
monarche: adjuvant abemaciclib endocrine therapy in patients with hr , her2- high-risk ebc
-
8:30
hr breast cancer: endocrine therapy, surgery and radiotherapy
-
4:16
adjuvant treatment for stage i her2 breast cancer
-
22:48
adjuvant therapy of breast cancer
-
2:16
when is surgery needed before adjuvant therapy in breast cancer?
-
30:56
adjuvant treatment for early stage hormone positive breast cancer: role of genomic signatures
-
1:15
remaining questions regarding the use of adjuvant chemotherapy in breast cancer
-
1:26
rxponder: chemotherapy and endocrine therapy in hr /her2- breast cancer
-
3:48
adjuvant therapy for breast cancer - mayo clinic
-
4:11
the latest in neo-adjuvant therapy for luminal breast cancer